More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...
Super Bowl LIX champion Dallas Goedert of the Philadelphia Eagles shares his journey with plaque psoriasis. After 20 years of ...
Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.
A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.
Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal ...
Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...
Published results showed “Latine” patients with psoriasis in the U.S. have unique experiences with their disease and ...
It was theorized that those patients using CAM may have been less inclined to utilize conventional medical treatments. However, in a Norwegian study, 42% of patients with psoriasis had pursued ...
Knowing which kind of psoriasis you have helps you and your doctor make a treatment plan. Most people have only one type at a time. Experts believe psoriasis is an autoimmune disease.
Not a lot of people know about psoriasis which is why several myths and misconceptions about the condition continue to ...
In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results